Pharmacoeconomic Evaluation of Antidiabetic Medication in Geriatric Type 2 Diabetes- A Brief Study

• DOI: 10.5455/njppp.2024.v14.i12.21
• Publication Date: 2025-01-10T21:48:31Z
• Authors: Arun Jakhar; Sartaj Hussain; Mohd Hussain; Lubna Saifi; Kauser Usman; K Sawlani; Sanjay Khattri
• Keywords: Glimepiride; Pharmacoeconomics; Outpatient clinic

Introduction: Diabetes mellitus (DM) is a long-term condition that poses enormous health and economic burden on society. Unfortunately, there dearth of such evidence in India. Hence, we sought to estimate the direct cost antidiabetic medication geriatric population. Aim Objectives: The aim this study evaluate pharmacoeconomic type 2 diabetes patients attending outpatient department tertiary care teaching hospital Materials Methods: demographic characteristics, clinical treatment profiles were compiled. All diabetic who visited an had their prescriptions recorded. A analysis prescribed anti-diabetic medications was conducted. Results: enrolled 600 DM patients, which 67.83% males, 32.17 % females, predominant age group 60-64 years. In 94.54% most frequently drug metformin 500 mg. 39.31% combination glimepiride mg + Insulin 14.83% cases. percentage difference for ranges from 43.010 644.444. monthly monotherapy with controlled (31.46%) uncontrolled (42.12%) between 1000 INR. addition, therapy INR 118.91 300.27. Conclusion: costs associated are immense impose substantial Consequently, policymakers should prioritise preventing disease its problems.